<DOC>
	<DOCNO>NCT01902693</DOCNO>
	<brief_summary>Human Immunodeficiency Virus ( HIV ) infection successfully treat type therapy call Highly Active AntiRetroviral Therapy ( HAART ) . Although HAART make great improvement health live people live HIV , HAART stop able 'cure ' eliminate HIV virus cell body - remain virus refer 'latent ' sleep virus . As soon HAART treatment stop virus come back ( wake ) . It reason stop HAART treatment recommend . However , may drug give HAART could stronger effect latent virus . There evidence laboratory research suggest drug use treat certain type cancer may effect latent virus . The purpose research study use new laboratory research technology measure amount 'latent ' virus people treat HAART need use chemotherapy treatment cancer . We look whether level HIV virus reduce patient chemotherapy look virus level , chemotherapy treatment . We know much HIV persist body despite therapy unless new approach develop , removal HIV virus cell body possible .</brief_summary>
	<brief_title>Prospective HIV Chemotherapy Cohort Study</brief_title>
	<detailed_description>STUDY DESIGN This study perform one investigational site UK . This single centre , prospective observational cohort study HIV positive individual suppressive HAART malignancy undergo chemotherapy . ELIGIBILITY Individuals receive HAART diagnose either lymphoma Kaposi 's sarcoma receive combination chemotherapy agent , include vinca alkaloid taxanes , eligible study .</detailed_description>
	<criteria>Aged â‰¥ 18 year able give write informed consent Be aware HIV status diagnosis malignancy Have plasma viral load &lt; 50 HIV1 RNA copies/ml ( suppressive HAART ) enrolment Be designate receive cytotoxic chemotherapy include one follow agent : RCHOP , ABVD , Liposomal doxorubicin ( Caelyx ) liposomal daunorubicin ( Daunoxome ) Paclitaxel Patients receive HAART A detectable ( &gt; 50 HIV1 RNA copies/ml ) HIV plasma viral load screen Opportunistic infection Unable unwilling give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Cohort</keyword>
	<keyword>Cancer</keyword>
	<keyword>HAART</keyword>
	<keyword>Malignancy</keyword>
</DOC>